<DOC>
	<DOC>NCT01465152</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to compare the efficacy of metformin and repaglinide used alone or combined administered as initial treatment in subjects with type 2 diabetes in which diet and exercise have failed.</brief_summary>
	<brief_title>Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subjects with type 2 diabetes Treated by diet for at least 3 months Never treated with hypoglycaemic drugs HbA1c (glycaemic haemoglobin A1c) on inclusion time superior to 6.5% Very symptomatic diabetes Advanced vascular complications Manifest renal failure Manifest hepatic disease Pregnancy, breast feeding or intention to become pregnant or if it is considered that the patient is not using adequate contraceptive measures. Adequate contraceptive measures are considered to be an intrauterine device, oral contraceptives and barrier methods</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>